Skip to main content

Featured

Daily Markets Update: Nasdaq Hits Record as Yields Top 5.3%, TSX Flat, Loonie Near 70¢

  S&P/TSX 35,518.55 +0.04% S&P 500 7,773.99 +0.66% Nasdaq 27,477.31 +1.05% Brent US$100.42 -1.8% USD/CAD 1.4250 Flat US 10-yr 5.315% +3.8 bp Monday, October 5 close, with Asia’s Tuesday session. Wall Street’s tech rally pushed the Nasdaq to a fresh record on Monday even as long-term bond yields kept climbing: the U.S. 10-year Treasury yield settled at 5.315%, a new 52-week high. Canada’s TSX barely moved, with tech gains offsetting a slide in energy and financials, and Cenovus fell after unveiling a C$5.7-billion takeover of Athabasca Oil. Oil dropped nearly 2% as G7 emergency stock releases and rising Middle East exports eased supply fears, and the loonie hovered near 70 U.S. cents, close to its weakest level in about 18 months. Canada: TSX Flat as Tech Offsets Energy Index / Stock Close Change S&P/TSX Composite 35,518.55 +0.04% Shopify (SHOP) — +5.7% Athabasca Oil (ATH) — +13.5% Cenovus Energy (CVE) C$44.86 -3.0% Suncor Energy (SU) — -1.2% The TSX added 15.90 points ...
Post a Comment
Read more

article

Labels

Stock Futures Steady as Investors Await Fresh Jobs Data

U.S. stock futures were little changed on Thursday as Wall Street attempted to recover from recent declines. Futures tied to the S&P 500 were flat, while Nasdaq futures rose slightly. Dow Jones Industrial Average futures fell marginally.

Labor Market Update: Today’s spotlight is on the release of the report on initial weekly jobless claims. A positive number could reassure traders about the state of the jobs market, while a negative one may introduce more turbulence. Last week’s sluggish non-farm payrolls update was one of the catalysts for recent declines.

Individual Movers:

  • Nvidia (NVDA): The AI giant’s stock is in focus after a back-and-forth day left it down another 5%.
  • Eli Lilly (LLY): The company’s stock soared over 10% in premarket trading after boosting its annual revenue and profit forecasts on strong weight-loss drug sales.


Labels:

Comments

Post a Comment